Showing items 1 to3 of 6

Medium
Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast
drugs

Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs

January 8, 2026

Learn More
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast
physician
healthcare

Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare

December 19, 2025

Learn More
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast
primary care
health

Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health

December 12, 2025

Learn More
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast
pharmacy

Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin

November 28, 2025

Learn More
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD
Podcast
specialty pharmacy
pharmacy

Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD

November 14, 2025

Learn More
Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD
Podcast
value-based care
healthcare podcast

Podcast 192: Making Value-Based Care Work at Scale w/ David Carmouche, MD

October 31, 2025

Learn More
Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb
Podcast
2025
value-based care

Podcast 191: Curing Nursing Burnout Through Education w/ Dr. Adele Webb

October 17, 2025

Learn More
Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP
Podcast
2025
leadership

Podcast 190: The New Rules of Health System Leadership w/ John D’Angelo, MD, FACEP

October 3, 2025

Learn More
Podcast 189: Fighting Back Against Insurance Denials w/ Neal Shah
Podcast
insurance
2025

Podcast 189: Fighting Back Against Insurance Denials w/ Neal Shah

September 19, 2025

Learn More
Podcast 188: Treating Healthcare's Misinformation Problem w/ Dr. Geeta Nayyar
Podcast
2025
healthcare

Podcast 188: Treating Healthcare's Misinformation Problem w/ Dr. Geeta Nayyar

September 5, 2025

Learn More
Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill
Insight
health

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

January 5, 2026

Learn More
Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products
Insight
drugmaker

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

December 22, 2025

Learn More
Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
Insight
ourtake

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

January 14, 2026

Learn More
Our Take: Eli Lilly achieves market value of $1 trillion
Insight
Eli Lilly

Our Take: Eli Lilly achieves market value of $1 trillion

December 8, 2025

Learn More
Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences
Insight
Cigna

Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences

November 24, 2025

Learn More
Our Take: CMS launches payment model to lower Medicaid drug spending
Insight
UnitedHealthcare

Our Take: CMS launches payment model to lower Medicaid drug spending

November 17, 2025

Learn More
Our Take: Pfizer wins bidding war to acquire Metsera
Insight
Pfizer

Our Take: Pfizer wins bidding war to acquire Metsera

November 10, 2025

Learn More
Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
Insight
PBM

Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs

November 3, 2025

Learn More
Our Take: An uptick in health system collaborations and affiliations
Insight
2025

Our Take: An uptick in health system collaborations and affiliations

October 27, 2025

Learn More
Our Take: Amazon to offer pharmacy kiosks at One Medical clinics
Insight
amazon

Our Take: Amazon to offer pharmacy kiosks at One Medical clinics

October 13, 2025

Learn More
Our Take: New California laws take aim at PBMs and more
Insight
PBM

Our Take: New California laws take aim at PBMs and more

October 20, 2025

Learn More
Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies
Insight
big pharma

Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies

September 22, 2025

Learn More
Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion
Insight
acquisition

Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion

October 6, 2025

Learn More
Our Take: Feature - GAO report on physician consolidation
Insight
acquisition

Our Take: Feature - GAO report on physician consolidation

September 29, 2025

Learn More
Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years
Insight
drug

Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years

September 15, 2025

Learn More
Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics
Insight
healthcare

Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics

September 8, 2025

Learn More
Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting
Insight
artificial intelligence

Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting

August 25, 2025

Learn More
Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada
Insight
canada

Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada

December 5, 2020

Learn More
Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health
Insight
insurers

Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health

October 12, 2020

Learn More
Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests
Insight
hospital market concentrations

Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests

October 19, 2021

Learn More
Our Take: Health System Executive Survey — observations from the editor
Insight
health system

Our Take: Health System Executive Survey — observations from the editor

October 26, 2020

Learn More
Our Take: Intermountain Healthcare, Sanford Health to merge
Insight
health

Our Take: Intermountain Healthcare, Sanford Health to merge

November 2, 2020

Learn More
Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions
Insight
CMS

Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions

November 9, 2020

Learn More
Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA
Insight
vaccine

Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA

November 16, 2020

Learn More
Our Take: Amazon rattles the pharmacy industry with its long-awaited launch
Insight
pharma

Our Take: Amazon rattles the pharmacy industry with its long-awaited launch

November 23, 2020

Learn More
Our Take: CMS reverses course, issues final rule to update Stark Law
Insight
CMS

Our Take: CMS reverses course, issues final rule to update Stark Law

December 7, 2020

Learn More
Our Take: Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine
Insight
biogen

Our Take: Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine

December 14, 2020

Learn More
Our Take: 2020’s (other) top stories
Insight
top 5

Our Take: 2020’s (other) top stories

December 21, 2020

Learn More
Our Take: Pharma companies sign spate of deals before year-end
Insight
pharma

Our Take: Pharma companies sign spate of deals before year-end

January 4, 2021

Learn More
Our Take: The demise of a proclaimed disrupter: Haven comes to a halt
Insight
Haven

Our Take: The demise of a proclaimed disrupter: Haven comes to a halt

January 11, 2021

Learn More
Our Take: CMS announces NextGen ACO results — and they are impressive
Insight
CMS

Our Take: CMS announces NextGen ACO results — and they are impressive

January 18, 2021

Learn More
Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020
Insight
unitedhealth

Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020

January 25, 2021

Learn More
Our Take: Leading drugmakers persist in the battle against COVID-19
Insight
drugmaker

Our Take: Leading drugmakers persist in the battle against COVID-19

February 1, 2021

Learn More
Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4
Insight
UnitedHealthcare

Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4

February 8, 2021

Learn More
Our Take: DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law
Insight
DOJ

Our Take: DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law

February 15, 2021

Learn More
Our Take: 14 health systems come together to create health data startup Truveta
Insight
multicare health system

Our Take: 14 health systems come together to create health data startup Truveta

February 22, 2021

Learn More
Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates
Insight
covid-19

Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates

March 1, 2021

Learn More
Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication
Insight
vaccine

Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication

March 8, 2021

Learn More
Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment
Insight
data

Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment

March 15, 2021

Learn More
Our Take: Amazon Care takes a potentially giant step forward
Insight
amarin corp

Our Take: Amazon Care takes a potentially giant step forward

March 22, 2021

Learn More
Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates
Insight
covid-19

Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates

March 29, 2021

Learn More
Our Take: Roundup of the latest COVID-19 vaccine news
Insight
covid cases

Our Take: Roundup of the latest COVID-19 vaccine news

April 5, 2021

Learn More
Our Take: Charity care spending at nonprofit hospitals falls short in new study
Insight
healthcare

Our Take: Charity care spending at nonprofit hospitals falls short in new study

April 12, 2021

Learn More
Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots
Insight
united states

Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots

April 19, 2021

Learn More
Our Take: Insurers continue to reap profits, announce acquisitions in Q1
Insight
insurers

Our Take: Insurers continue to reap profits, announce acquisitions in Q1

April 26, 2021

Learn More
Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion
Insight
Humana

Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion

May 3, 2021

Learn More
Our Take: Walmart to acquire on-demand telehealth provider MeMD
Insight
walmart

Our Take: Walmart to acquire on-demand telehealth provider MeMD

May 10, 2021

Learn More
Our Take: BD to spin off diabetes business into new publicly traded company
Insight
harvard business school

Our Take: BD to spin off diabetes business into new publicly traded company

May 17, 2021

Learn More
Our Take: JPMorgan Chase picks up where Haven left off
Insight
jpmorgan chase

Our Take: JPMorgan Chase picks up where Haven left off

May 24, 2021

Learn More
Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools
Insight
healthcare

Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools

June 7, 2021

Learn More
Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy
Insight
fda

Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy

June 14, 2021

Learn More
Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system
Insight
health

Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system

June 21, 2021

Learn More
Our Take: Blues plans fund new startup to address high drug prices
Insight
health plan

Our Take: Blues plans fund new startup to address high drug prices

June 28, 2021

Learn More
Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week
Insight
covid cases

Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week

July 12, 2021

Learn More
Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications
Insight
behavioral health

Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications

July 19, 2021

Learn More
Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm
Insight
integrated health systems

Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm

July 26, 2021

Learn More
Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars
Insight
fda

Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars

August 2, 2021

Learn More
Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows
Insight
covid-19

Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows

August 9, 2021

Learn More
Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care
Insight
home

Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care

August 16, 2021

Learn More
Our Take: J&J, Cerner announce shake-ups in top leadership, Google Health splitting up
Insight
Google Cloud

Our Take: J&J, Cerner announce shake-ups in top leadership, Google Health splitting up

August 23, 2021

Learn More
Our Take: Vaccine update: Pfizer, BioNTech get full FDA nod, Moderna completes its BLA submission
Insight
biobank

Our Take: Vaccine update: Pfizer, BioNTech get full FDA nod, Moderna completes its BLA submission

September 1, 2021

Learn More
Our Take: Biden administration takes a more aggressive stance in the battle against COVID-19
Insight
Biden

Our Take: Biden administration takes a more aggressive stance in the battle against COVID-19

September 13, 2021

Learn More
Our Take: Walgreens to invest nearly $1 billion in Shields Health Solutions
Insight
Walgreens

Our Take: Walgreens to invest nearly $1 billion in Shields Health Solutions

September 27, 2021

Learn More
Our Take: Northwell Health, Walgreens form new affiliation to improve care for tre-state area
Insight
virtual health

Our Take: Northwell Health, Walgreens form new affiliation to improve care for tre-state area

September 20, 2021

Learn More
Our Take: Merck, Ridgeback could be first to receive EUA for COVID-19 pill
Insight
covid-19

Our Take: Merck, Ridgeback could be first to receive EUA for COVID-19 pill

October 4, 2021

Learn More
Our Take: Intermountain, Presbyterian, SSM Health launch member-led company to ‘transform’ digital health care
Insight
health

Our Take: Intermountain, Presbyterian, SSM Health launch member-led company to ‘transform’ digital health care

October 11, 2021

Learn More
Our Take: Boehringer Ingelheim joins list of drugmakers facing possible penalties for violating 340B statute
Insight
drugmaker

Our Take: Boehringer Ingelheim joins list of drugmakers facing possible penalties for violating 340B statute

October 18, 2021

Learn More
Our Take: Value-based payment for prescription drugs: Will industry or the feds lead the way?
Insight
value

Our Take: Value-based payment for prescription drugs: Will industry or the feds lead the way?

October 25, 2021

Learn More
Our Take: Two new PBMs target high drug prices, lack of transparency
Insight
drug

Our Take: Two new PBMs target high drug prices, lack of transparency

November 1, 2021

Learn More
Our Take: New COVID-19 mandates could require millions more to be vaccinated by Jan. 4 unless lawsuits prevail
Insight
covid

Our Take: New COVID-19 mandates could require millions more to be vaccinated by Jan. 4 unless lawsuits prevail

November 8, 2021

Learn More
Our Take: Public health officials face steep challenge in fight against COVID-19 misinformation, KFF survey indicates
Insight
health

Our Take: Public health officials face steep challenge in fight against COVID-19 misinformation, KFF survey indicates

November 15, 2021

Learn More
Our Take: HHS will require health insurers to report data on prescription drug costs and coverage
Insight
health

Our Take: HHS will require health insurers to report data on prescription drug costs and coverage

November 22, 2021

Learn More
Our Take: FDA panel votes to authorize Merck, Ridgeback’s molnupiravir, despite lower efficacy in final trial results
Insight
fda

Our Take: FDA panel votes to authorize Merck, Ridgeback’s molnupiravir, despite lower efficacy in final trial results

December 6, 2021

Learn More
Our Take: Update on the omicron variant, vaccines, and other COVID-19 treatments
Insight
covid

Our Take: Update on the omicron variant, vaccines, and other COVID-19 treatments

December 13, 2021

Learn More
Our Take: 2021 in the rearview
Insight
2021

Our Take: 2021 in the rearview

December 19, 2021

Learn More
Our Take: Flurry of M&A activity marks end of 2021, spills over into 2022
Insight
2021

Our Take: Flurry of M&A activity marks end of 2021, spills over into 2022

January 10, 2022

Learn More
Our Take: Hospitals feel the strain of staff shortages with the omicron-fueled COVID-19 surge
Insight
covid

Our Take: Hospitals feel the strain of staff shortages with the omicron-fueled COVID-19 surge

January 17, 2022

Learn More
Our Take: Collaborations among health systems aim to improve efficiency, equity, experiences, and innovation
Insight
health news

Our Take: Collaborations among health systems aim to improve efficiency, equity, experiences, and innovation

January 24, 2022

Learn More
Our Take: Staffing agencies accused of exploiting nursing staff shortages, federal investigation requested
Insight
nurses

Our Take: Staffing agencies accused of exploiting nursing staff shortages, federal investigation requested

January 31, 2022

Learn More
Our Take: Humana seeks to create $1 billion in additional value to boost its Medicare Advantage business
Insight
Humana

Our Take: Humana seeks to create $1 billion in additional value to boost its Medicare Advantage business

February 7, 2022

Learn More
Our Take: Amazon achieves goal of rolling out virtual health services nationwide, plans to expand in-person care
Insight
amazon

Our Take: Amazon achieves goal of rolling out virtual health services nationwide, plans to expand in-person care

February 14, 2022

Learn More
Our Take: DOJ reportedly preparing lawsuit to prevent UnitedHealth from acquiring Change Healthcare
Insight
UnitedHealthcare

Our Take: DOJ reportedly preparing lawsuit to prevent UnitedHealth from acquiring Change Healthcare

February 21, 2022

Learn More
Our Take: Allscripts to sell its hospital business segment for up to $700 million
Insight
business

Our Take: Allscripts to sell its hospital business segment for up to $700 million

March 7, 2022

Learn More
Our Take: Jury finds in Sutter Health’s favor in class-action antitrust lawsuit
Insight
health

Our Take: Jury finds in Sutter Health’s favor in class-action antitrust lawsuit

March 14, 2022

Learn More
Our Take: Banner|Aetna joint venture: An ‘innovation laboratory’ touts its successes
Insight
innovation

Our Take: Banner|Aetna joint venture: An ‘innovation laboratory’ touts its successes

March 21, 2022

Learn More
Our Take: Full-risk payment models lead to less use of acute care and greater shared savings, but quality of care may suffer, data suggest
Insight
payment

Our Take: Full-risk payment models lead to less use of acute care and greater shared savings, but quality of care may suffer, data suggest

March 28, 2022

Learn More
Our Take: Final CMS policy: Aduhelm will be covered only in clinical trials
Insight
CMS

Our Take: Final CMS policy: Aduhelm will be covered only in clinical trials

April 18, 2022

Learn More
Our Take: Independent physician practices succumbed to buyouts during the pandemic
Insight
pandemic

Our Take: Independent physician practices succumbed to buyouts during the pandemic

April 25, 2022

Learn More
Our Take: AHA says more than one-third of hospitals now operating on negative margins because of ‘skyrocketing’ expenses
Insight
university hospital

Our Take: AHA says more than one-third of hospitals now operating on negative margins because of ‘skyrocketing’ expenses

May 2, 2022

Learn More
Our Take: Aduhelm torpedoed Biogen. Will lecanemab — or a new CEO — come to the rescue?
Insight
ceo

Our Take: Aduhelm torpedoed Biogen. Will lecanemab — or a new CEO — come to the rescue?

May 9, 2022

Learn More
Our Take: Advocate Aurora, Atrium Health plan to combine, creating a $27 billion health system
Insight
advocate health care

Our Take: Advocate Aurora, Atrium Health plan to combine, creating a $27 billion health system

May 16, 2022

Learn More
Our Take: Humana’s second JV with WCAS will invest up to $1.2 billion to open more value-based primary care clinics
Insight
Humana

Our Take: Humana’s second JV with WCAS will invest up to $1.2 billion to open more value-based primary care clinics

May 23, 2022

Learn More
Our Take: Pressure mounts for Congress, FTC to crack down on PBM practices
Insight
prescription

Our Take: Pressure mounts for Congress, FTC to crack down on PBM practices

June 6, 2022

Learn More
Our Take: SCOTUS sides with hospitals, says HHS ‘acted unlawfully’ in cutting 340B payments
Insight
hospital

Our Take: SCOTUS sides with hospitals, says HHS ‘acted unlawfully’ in cutting 340B payments

June 20, 2022

Learn More
Our Take: As anticipated, FTC will investigate business practices of largest PBMs
Insight
business

Our Take: As anticipated, FTC will investigate business practices of largest PBMs

June 13, 2022

Learn More
Our Take: FTC, lawmakers focus on insulin in continued attempts to make prescription drugs more affordable
Insight
insulin

Our Take: FTC, lawmakers focus on insulin in continued attempts to make prescription drugs more affordable

June 27, 2022

Learn More
Our Take: CMS introduces new oncology care model, proposes changes to Medicare Shared Savings Program
Insight
CMS

Our Take: CMS introduces new oncology care model, proposes changes to Medicare Shared Savings Program

July 11, 2022

Learn More
Our Take: Northwell Health, New York-Presbyterian form separate partnerships to advance patient care through AI
Insight
blue cross blue shield of north carolina

Our Take: Northwell Health, New York-Presbyterian form separate partnerships to advance patient care through AI

July 18, 2022

Learn More
Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion
Insight
amazon

Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion

July 25, 2022

Learn More
Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell
Insight
Humana

Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell

August 1, 2022

Learn More